Where Are We Now with Liver Transplantation in Neuroendocrine Neoplasms? The Place of Liver Transplantation for Grades 1 and 2 Well-Differentiated Unresectable Liver Metastatic Neuroendocrine Tumours

[1]  A. M. Shapiro,et al.  Machine Perfusion of the Liver: Applications Beyond Transplantation , 2020, Transplantation.

[2]  N. Terrault,et al.  Liver transplantation as therapy for hepatocellular carcinoma , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[3]  S. Dueland,et al.  Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases. , 2020, Annals of surgery.

[4]  A. S. Lima,et al.  Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study: clinical profile and prognostic factors of survival , 2019, European journal of gastroenterology & hepatology.

[5]  K. Zieniewicz,et al.  2018 Annual Report of the European Liver Transplant Registry (ELTR) – 50‐year evolution of liver transplantation , 2018, Transplant international : official journal of the European Society for Organ Transplantation.

[6]  Shouhao Zhou,et al.  Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States , 2017, JAMA oncology.

[7]  T. Pawlik,et al.  Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review , 2017, Surgery.

[8]  E. Nakakura,et al.  The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society , 2017, Pancreas.

[9]  L. Mariani,et al.  The Long‐Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  James C Yao,et al.  Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study , 2016, The Lancet.

[11]  E. Krenning,et al.  ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site , 2016, Neuroendocrinology.

[12]  V. Mazzaferro,et al.  Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial , 2015, Transplantation.

[13]  E. D. de Vries,et al.  Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  D. Goldberg,et al.  Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes , 2015, Transplantation.

[15]  S. Groshen,et al.  Liver transplantation for metastatic neuroendocrine tumors: Outcomes and prognostic variables , 2015, Journal of surgical oncology.

[16]  A. Kennedy.  Liver metastases from neuroendocrine tumors. , 2014, Future oncology.

[17]  B. Gornicka,et al.  Outcomes following liver transplantation for metastatic neuroendocrine tumors. , 2014, Transplantation proceedings.

[18]  F. Lehner,et al.  Everolimus and Early Calcineurin Inhibitor Withdrawal: 3-Year Results From a Randomized Trial in Liver Transplantation , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  G. Åkerström,et al.  Indication for Liver Transplantation in Young Patients with Small Intestinal NETs Is Rare? , 2014, World Journal of Surgery.

[20]  F. Pruvot,et al.  Liver Transplantation for Neuroendocrine Tumors in Europe—Results and Trends in Patient Selection: A 213-Case European Liver Transplant Registry Study , 2013, Annals of surgery.

[21]  K. Boberg,et al.  Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer , 2013, Annals of surgery.

[22]  W. Chapman,et al.  Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  Johnny C. Hong,et al.  Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. , 2012, Gastroenterology.

[24]  J. Goss,et al.  Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: The US Experience , 2011, International journal of hepatology.

[25]  S. Beckebaum,et al.  Liver Transplantation for Hepatic Metastases of Neuroendocrine Pancreatic Tumors: A Survival-Based Analysis , 2011, Transplantation.

[26]  V. Mazzaferro,et al.  Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? , 2007, Journal of hepatology.

[27]  O. Nilsson,et al.  Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[28]  G. Gores,et al.  Model for end‐stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[29]  G. Gerken,et al.  Liver transplantation for patients with metastatic endocrine tumors: Single‐center experience with 15 patients , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[30]  G. Gores,et al.  Liver Transplantation with Neoadjuvant Chemoradiation is More Effective than Resection for Hilar Cholangiocarcinoma , 2005, Annals of surgery.

[31]  M. Manns,et al.  Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. , 2002, Transplantation.

[32]  G. Gores,et al.  Prolonged disease‐free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[33]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[34]  T. Starzl,et al.  Liver transplantation: an unfinished product. , 1989, Transplantation proceedings.

[35]  C. Cooper,et al.  Addenbrooke's Hospital , 1898, The Hospital.